2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neuroendocrine Tumors
3
Lung Neoplasms
3
Breast Neoplasms
3
Respiratory Insufficiency
1
Radiation Pneumonitis
1
Prostatic Neoplasms
1
Parkinson Disease
1
Lymphoma, Non-Hodgkin
1
Lung Diseases
1
Hodgkin Disease
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Abnormalities, Radiation-Induced
1
Interventions
Carboplatin
19
Pemetrexed
10
Paclitaxel
7
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
Bronchoscopy
3
zipalertinib
2
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Drug Delivery Systems
2
Docetaxel
2
Blood Specimen Collection
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
taletrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Diseases
×
Tomography, Emission-Computed, Single-Photon
×
Clear all
NCT04676828
2026-02-24
ASPECT
University of Aarhus
Phase NA
Recruiting
90 enrolled